Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab

Nephrology

Volumn 21, Issue , 2016, Pages 35-40

  Ikeda, Takashi ^a   Okumi, Masayoshi ^a   Unagami, Kohei ^a   Kanzawa, Taichi ^a   Sawada, Anri ^a   Kawanishi, Kunio ^a   Omoto, Kazuya ^a   Ishida, Hideki ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

atypical haemolytic uraemic syndrome; eculizumab; kidney transplantation; plasma exchange; thrombotic microangiopathies

Indexed keywords

BASILIXIMAB; CIPROFLOXACIN; CREATININE; ECULIZUMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RITUXIMAB; TACROLIMUS; COMPLEMENT INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CREATININE BLOOD LEVEL; DESENSITIZATION; DOPPLER ULTRASONOGRAPHY; DOUBLE FILTRATION PLASMAPHERESIS; END STAGE RENAL DISEASE; FEMALE; FIBRIN CLOT; FIBROSING ALVEOLITIS; HEMODIALYSIS; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE (PEOPLE); KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LACTATE DEHYDROGENASE BLOOD LEVEL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEUTROPHIL CHEMOTAXIS; PLASMAPHERESIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUBULAR ATROPHY; ADVERSE EFFECTS; ALLOGRAFT; BIOPSY; COMPLEMENT ACTIVATION; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; PATHOLOGY; REMISSION; THROMBOTIC MICROANGIOPATHIES; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ALLOGRAFTS; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOPSY; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATING AGENTS; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; REMISSION INDUCTION; THROMBOTIC MICROANGIOPATHIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84976534215     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12768     Document Type: Article

References (14)

1. Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi V, Legendre C. New insights into postrenal transplant hemolytic uremic syndrome. Nat. Rev. Nephrol. 2011; 7: 23–35.
2. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009; 361: 1676–87.
3. Zuber J, Le Quintrec M, Krid S et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. Am. J. Transplant. 2012; 12: 3337–54.
4. Dhakal P, Giri S, Pathak R, Bhatt VR. Eculizumab in Transplant-Associated Thrombotic Microangiopathy. Clin. Appl. Thromb. Hemost. 2015 2015 Aug 9. pii: 1076029615599439.
5. Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am. J. Transplant. 2010; 10: 1517–23.
6. Le Quintrec M, Lionet A, Kamar N et al. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am. J. Transplant. 2008; 8: 1694–701.
7. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2007; 18: 2392–400.
8. Chatelet V, Fremeaux-Bacchi V, Lobbedez T, Ficheux M, Hurault de Ligny B. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am. J. Transplant. 2009; 9: 2644–5.
9. Licht C, Greenbaum LA, Muus P et al. Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney Int. 2015; 87: 1061–73.
10. Mulay S, Kreuter JD, Bryant SC et al. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant. J. Clin. Apher. 2015; 30: 147–53.
11. Hillmen P, Young NS, Schubert J et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 2006; 355: 1233–43.
12. Rathbone J, Kaltenthaler E, Richards A, Tappenden P, Bessey A, Cantrell A. A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS). BMJ Open 2013; 3: e003573.
13. Campistol JM, Arias M, Ariceta G et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia 2013; 33: 27–45.
14. Struijk GH, Bouts AH, Rijkers GT, Kuin EA, ten Berge IJ, Bemelman FJ. Meningococcal sepsis complicating eculizumab treatment despite prior vaccination. Am. J. Transplant. 2013; 13: 819–20.